{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.2:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_198578.2:c.5096T>C",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "T",
            "alt": "C",
            "position": "5096"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_198578.2:c.7154G>C",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "G",
            "alt": "C",
            "position": "7154"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "2385"
          },
          "Description in input context": "G2385R"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005339"
  },
  "Experiment Method": [
    {
      "Assay Method": "Transgenic Drosophila Model",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Drosophila melanogaster",
        "Description": "Transgenic Drosophila overexpressing human LRRK2 G2019S, Y1699C, or G2385R variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Expression of G2019S mutant leads to significant degeneration of DA neurons in the PPM clusters 1 and 3, locomotion deficits, and increased sensitivity to rotenone."
        },
        {
          "Variant": "NM_198578.2:c.5096T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Expression of Y1699C mutant leads to significant degeneration of DA neurons in the PPM clusters 1 and 3, but not significant locomotion deficits."
        },
        {
          "Variant": "NM_198578.2:c.7154G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Expression of G2385R mutant leads to significant degeneration of DA neurons in the PPM clusters 1 and 3, similar to G2019S."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Flies expressing different LRRK2 variants were used as biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Multiple trials were performed for climbing assays and rotenone treatments."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing flies were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Control flies without transgenes were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Studentâ€™s t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant loss of DA neurons or locomotion deficits.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant loss of DA neurons or locomotion deficits.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}